Abstract
Infection of bovine arterial endothelial (BAE) cells with bovine herpesvirus-4 (BHV-4) induced biphasic activation of one of the cellular mitogen-activated protein kinase (MAPK) downstream targets, extracellular signal-regulated kinase (ERK). ERK activity reached a maximum within 0.5 h postinfection (h.p.i.), and had declined and returned to basal levels by 2 h.p.i. However, at 18–24 h.p.i., a second phase of increased ERK activation occurred. Treatment of BHV-4-infected BAE cells with either U0126, a potent inhibitor of MAPK/ERK kinase, or arsenite dose-dependently blocked ERK activation and inhibited viral DNA synthesis and viral replication in the culture. Further detailed investigations revealed that transcription of viral immediate-early gene 2 (IE-2), which is required for viral DNA replication, was significantly suppressed by both U0126 and arsenite. These results imply that ERK activation may play a pivotal role in herpesvirus replication, and that inhibition of ERK activation can effectively inhibit viral IE protein synthesis and viral replication.
Similar content being viewed by others
References
Alcorn MJ, Booth JL, Coggeshall KM, Metcalf JP. Adenovirus type 7 induces interleukin-8 production via activation of extracellular regulated kinase 1/2. J Virol 75:6450–6459;2001.
Amici C, Giorgi C, Rossi A, Santoro MG. Selective inhibition of virus protein synthesis by prostaglandin A1: A translational block associated with HSP70 synthesis. J Virol 68:6890–6899;1994.
Angelidis CE, Lazaridis I, Pagoulatos GN. Specific inhibition of simian virus 40 protein synthesis by heat and arsenite treatment. Eur J Biochem 172:27–34;1988.
Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE. Arsenic induces oxidant stress and NF-κB activation in cultured aortic endothelial cells. Free Radic Biol Med 21:783–790;1996.
Bazarbachi A, El-Sabban ME, Nasr R, Quignon F, Awaraji C, Kersual J, Dianoux L, Zermati Y, Haidar JH, Hermine O, de Thé H. Arsenic trioxide and interferon-α synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Blood 93:278–283;1999.
Benn J, Su F, Doria M, Schneider RJ. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 70:4978–4985;1996.
Bermudez-Cruz R, Zhang L, Van Santen VL. Characterization of a bovine herpesvirus 4 (BHV-4) 1.1-kb RNA and its transactivation by BHV-4 immediate-early 2 gene product. Arch Virol 143:2391–2412;1998.
Boyle KA, Pietropaola RL, Compton T. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol Cell Biol 19:3607–3613;1999.
Bruder JT, Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 71:398–404;1997.
Bublot M, Lomonte P, Lequarre AS, Albrecht JC, Nicholas J, Fleckenstein B, Pastoret PP, Thiry E. Genetic relationships between bovine herpesvirus 4 and the gammaherpesviruses Epstein-Barr virus and Herpesvirus saimiri. Virology 190:654–665;1992.
Castrucci G, Frigeri F, Ferrari M, Di Luca D, Traldi V. A study of some biologic properties of bovid herpesvirus-4. Comp Immunol Microbiol Infect Dis 14:197–207;1991.
Chang LY, Van Santen VL. Immediate-early, early, and late RNAs in bovine herpesvirus-4-infected cells. Virology 191:909–920;1992.
Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88:1052–1061;1996.
Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553–14556;1993.
Egyed L. Bovine herpesvirus type 4: A special herpesvirus (review article). Acta Vet Hung 48:501–513;2000.
Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623–18632;1998.
Frost JA, Geppert TD, Cobb MH, Feramisco JR. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci USA 91:3844–3848;1994.
Healy SM, Casarez EA, Ayala-Fierro F, Aposhian HV. Enzymatic methylation of arsenic compounds. Toxicol Appl Pharmacol 148:65–70;1998.
Hsiung GD. Virus assay procedures. In: Hsiung GD, Fong CKY, Landry ML, eds. Hsiung's Diagnostic Virology, ed 4. New Haven, Yale University, 46–55;1994.
Hsueh YM, Wu WL, Huang YL, Chiou HY, Tseng CH, Chen CJ. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 141:249–257;1998.
Jacqué JM, Mann A, Enslen H, Sharova N, Brichacek B, Davis RJ, Stevenson M. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J 17:2607–2618;1998.
Johnson RA, Huong SM, Huang ES. Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole on HCMV DNA replication and permissive infection. Antiviral Res 41:101–111;1999.
Johnson RA, Huong SM, Huang ES. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: A novel mechanism for activation of p38. J Virol 74:1158–1167;2000.
Johnson RA, Ma XL, Yurochko AD, Huang ES. The role of MKK1/2 kinase activity in human cytomegalovirus infection. J Gen Virol 82:493–497;2001.
Kim JY, Choi JA, Kim TH, Yoo YD, Kim JI, Lee YJ, Yoo SY, Cho CK, Lee YS, Lee SJ. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J Cell Physiol 190:29–37;2002.
König A, Wrazel L, Warrell RP Jr, Rivi R, Pandolfi PP, Jakubowski A, Gabrilove JL. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood 90:562–570;1997.
Lee TC, Wuu-Wang S, Huang RY, Lee KCC, Jan KY. Differential effects of pre- and post-treatment of sodium arsenite on the genotoxicity of methyl methanesulfonate in Chinese hamster ovary cells. Cancer Res 46:1854–1857;1986.
Lin TM, Jiang MJ, Eng HL, Shi GY, Lai LC, Huang BJ, Huang KY, Wu HL. Experimental infection with bovine herpesvirus-4 enhances atherosclerotic process in rabbits. Lab Invest 80:3–11;2000.
Lin TM, Shi GY, Jiang SJ, Tsai CF, Hwang BJ, Hsieh CT, Wu HL. Persistent infection of bovine herpesvirus type 4 in bovine endothelial cell cultures. Vet Microbiol 70:41–53;1999.
Lin TM, Shi GY, Tsai CF, Su HJ, Gou YL, Wu HL. Susceptibility of endothelial cells to bovine herpesvirus type 4 (BHV-4). J Virol Methods 63:219–225;1997.
Liu L, Trimarchi JR, Navarro P, Blasco MA, Keefe DL. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability and apoptosis. J Biol Chem 278:31998–32004;2003.
Liu Y, Guyton KZ, Gorospe M, Xu Q, Lee JC, Holbrook NJ. Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radic Biol Med 21:771–781;1996.
Lomonte P, Bublot M, van Santen VL, Keil GM, Pastoret PP, Thiry E. Bovine herpesvirus 4: Genomic organization and relationship with two other gammaherpesviruses, Epstein-Barr virus and herpesvirus saimiri. Vet Microbiol 53:79–89;1996.
Ludwig S, Hoffmeyer A, Goebeler M, Kilian K, Häfner H, Neufeld B, Han J, Rapp UR. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J Biol Chem 273:1917–1922;1998.
Marshall CJ. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–85;1995.
McLean TI, Bachenheimer SL. Activation of c-Jun N-terminal kinase by herpes simplex virus type 1 enhances viral replication. J Virol 73:8415–8426;1999.
Planz O, Pleschka S, Ludwig S. MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J Virol 75:4971–4877;2001.
Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signaling cascade. Nat Cell Biol 3:301–305;2001.
Popik W, Pitha PM. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor. Virology 252:210–217;1998.
Rodems SM, Spector DH. Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J Virol 72:9173–9180;1998.
Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027–1037;1994.
Seo M, Lee YI, Cho CH, Bae CD, Kim IH, Juhnn YS. Bi-directional regulation of UV-induced activation of p38 kinase and c-Jun N-terminal kinase by G protein beta gamma-subunits. J Biol Chem 277:24197–203;2002.
Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89:3354–3360;1997.
Shi GY, Hau JS, Wang SJ, Wu IS, Chang BI, Lin MT, Chow YH, Chang WC, Wing, LYC, Jen CJ, Wu HL. Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells. J Biol Chem 267:19363–19368;1992.
Staczek J. Animal cytomegaloviruses. Microbiol Rev 54:247–265;1990.
Storz J, Ehlers B, Todd WJ, Ludwing H. Bovine cytomegaloviruses: Identification and differential properties. J Gen Virol 65:697–706;1984.
Thiry E, Bublot M, Dubuisson J, Van Bressem MF, Lequarre AS, Lomonte P, Vanderplasschen A, Pastoret PP. Molecular biology of bovine herpesvirus type 4. Vet Microbiol 33:79–92;1992.
Van Santen VL. Characterization of the bovine herpesvirus 4 major immediate-early transcript. J Virol 65:5211–5224;1991.
Van Santen VL. Characterization of a bovine herpesvirus 4 immediate-early RNA encoding a homolog of the Epstein-Barr virus R transactivator. J Virol 67:773–784;1993.
Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LH, Hsueh YM, Chiou HY, Wu MM, Chen CJ. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105:1804–1809;2002.
Yang X, Gabuzda D. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol 73:3460–3466;1999.
Yurochko AD, Mayo MW, Poma EE, Baldwin AS Jr, Huang ES. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters. J Virol 71:4638–4648;1997.
Zachos G, Clements B, Conner J. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J Biol Chem 274:5097–5103;1999.
Zhang L, Van Santen VL. Interaction of bovine herpesvirus 4 (BHV-4) immediate early 2 gene product with BHV-4 thymidine kinase promoter-regulatory region. J Gen Virol 76:2433–2445;1995.
Zheng J, Deng YP, Lin C, Fu M, Xiao PG, Wu M. Arsenic trioxide induces apoptosis of HPV 16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression. Int J Cancer 82:286–292;1999.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jiang, SJ., Lin, TM., Shi, GY. et al. Inhibition of bovine herpesvirus-4 replication by arsenite through downregulation of the extracellular signal-regulated kinase signaling pathway. J Biomed Sci 11, 500–510 (2004). https://doi.org/10.1007/BF02256099
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02256099